|
⚲
|
| Keyboard |
| James Eadie | |
|---|---|
| Firm | |
| Address | 155 Chain Lake Drive, Unit 32 Halifax, A5 B3S 1B3 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| ABK Biomedical Inc | 021-562869 | Director | 2.6 M of 2.6 M |
||
| Cryosa Inc | 021-553452 | Director | 6.0 M of 15.0 M |
||
| Reprieve Cardiovascular Inc | 021-548181 | Director | 30.9 M of 35.9 M |
||
| ABK Biomedical Inc | 021-545979 | Director | 26.1 M of 26.1 M |
||
| Reprieve Cardiovascular Inc | 021-525646 | Director | 9.5 M of 10.5 M |
||
| Endogenex Inc | 021-516663 | Director | 69.6 M of 89.6 M |
||
| Reprieve Cardiovascular Inc | 021-497709 | Director | 12.1 M of 12.1 M |
||
| Geneos Therapeutics Inc | 021-478663 | Director | 5.0 M of 10.0 M |
||
| Rapidpulse Inc | 021-457623 | Director | 10.6 M of 10.6 M |
||
| Reprieve Cardiovascular Inc | 021-448461 | Director | 15.0 M of 15.0 M |
||
| Pulseon Inc | 021-400619 | Director | 15.0 M of 15.0 M |
||
| Dyamx Inc | 021-396418 | Director | 12.0 M of 12.0 M |
||
| Geneos Therapeutics Inc | 021-380790 | Director | 10.4 M of 12.0 M |
||
| Reprieve Cardiovascular Inc | 021-372471 | Director | 15.0 M of 15.0 M |
||
| Geneos Therapeutics Inc | 021-333669 | Director | 4.5 M of 10.5 M |
||
| Dyamx Inc | 021-327260 | Director | 12.8 M of 12.8 M |
||
| Farapulse Inc | 021-319020 | Director | 12.0 M of 12.0 M |
||
| Beta Cat Pharmaceuticals Inc | 021-315497 | Director | 2.6 M of 6.0 M |
||
| Millipede Inc | 021-305231 | Director | 43.2 M of 43.2 M |
||
| Claret Medical Inc | 021-290809 | Director | 21.2 M of 21.2 M |
||
| Iowa Approach Inc | 021-290358 | Director | 5.0 M of 5.0 M |
||
| Iowa Approach Inc | 021-258524 | Director | 15.0 M of 24.0 M |
||
| TVA Medical Inc | 021-249171 | Director | 15.3 M of 15.3 M |
||
| Claret Medical Inc | 021-224196 | Director | 16.8 M of 26.0 M |
||